EnLyte-D | Normalizing Brain Chemistry

FDA Approved Medical Food

"EnLyte-D provides all bioactive coenzyme & cofactors needed for optimal neurotransmitter synthesis, optimal antioxidant production, and optimal homocysteine reduction. The high prevalence of MTHFR and other inborn errors of metabolism (IEM’s) seen in neurological disease argue for treatment EnLyte-D."
Andrew Farah, MD, Chief of Psychiatry, UNC/HPRHS

INDICATED FOR THE CLINICAL DIETARY MANAGEMENT OF:

 

Major Depressive Disorder

 

Addiction and/or Abuse Abatement

 

Cognitive Dysfunction/Dementia/Alzheimer’s

 

Peripheral Neuropathic Pain/Tingling

 

Early and End-Stage Renal Disease

 

Migraine

 

Age-Related Macular Degeneration



EnLyte-D is an FDA approved medical food to be used under medical supervision that has been specifically formulated for patients with methylenetetrahydrofolate reductase (MTHFR) genotypes and/or genotypes in Vitamin D transport and other B-Vitamin polymorphisms that may contribute to hyperhomocysteinemia and/or Vitamin D deficiency. EnLyte-D provides patients special, medically determined nutrient requirements including L-Methylfolate, Vitamin D, and other B vitamin coenzymes and mineral co-factors in amounts that cannot be achieved by the modification of the normal diet alone.


DOWNLOAD PI FOR FULL DESCRIPTION